Fig. 1: Trial profile.
*One patient permanently discontinued the study treatment after developing continuous grade 2 hypothyroidism and one patient permanently discontinued the study treatment due to grade 3 myocardial infarction.
Fig. 1: Trial profile. | Nature Communications
